#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3361952	B	Agonist activity at human TAS2R14 expressed in U2OS cells by Ga16gust44 Clone 7A FLIPR/summary (Abse5) assay	Homo sapiens	1		cell-based format	Scientific Literature
2.	ALA3361953	B	Antagonist activity at human TAS2R14 expressed in U2OS cells by Ga16gust44 Clone 7A FLIPR/summary (Abse5) assay	Homo sapiens	1		cell-based format	Scientific Literature
3.	ALA3887148	B	Fluorescence Polarization Assays: In another embodiment, Fluorescence Polarization ("FP") based assays may be used to detect and monitor ligand binding. Fluorescence polarization is a versatile laboratory technique for measuring equilibrium binding, nucleic acid hybridization, and enzymatic activity. Fluorescence polarization assays are homogeneous in that they do not require a separation step such as centrifugation, filtration, chromatography, precipitation, or electrophoresis. These assays are done in real time, directly in solution and do not require an immobilized phase. Polarization values can be measured repeatedly and after the addition of reagents since measuring the polarization is rapid and does not destroy the sample. Generally, this technique can be used to measure polarization values of fluorophores from low picomolar to micromolar levels.		116		single protein format	BindingDB Database
4.	ALA4346430	F	Antagonist activity at recombinant human TAS2R14 transiently expressed in HEK293T co-expressing Galpha16gust44 assessed as inhibition of aristolochic acid-induced intracellular calcium level by measuring remaining activity at 25 uM by fluo-4AM dye based FLIPR assay relative to control	Homo sapiens	2		cell-based format	Scientific Literature
5.	ALA4346442	B	Agonist activity at TAS2R14 (unknown origin) at 25 uM by transiently expressed cell-based assay	Homo sapiens	1		cell-based format	Scientific Literature
6.	ALA4346444	B	Agonist activity at TAS2R14 (unknown origin) by stably expressed cell-based assay	Homo sapiens	1		cell-based format	Scientific Literature
7.	ALA4419006	F	Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R14 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as increase in intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	2		cell-based format	Patent Bioactivity Data
8.	ALA4419041	F	Antagonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R14 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as inhibition of aristolochic acid-induced increase in intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	2		cell-based format	Patent Bioactivity Data
9.	ALA4419132	F	Activity at human TAS2R14 expressed in HEK-293T-Galpha16-gustducin44 cells assessed as concentration of compound which reacts with receptor by measuring calcium response by FLIPR assay	Homo sapiens	1		cell-based format	Patent Bioactivity Data
10.	ALA4419217	F	Agonist activity at human TAS2R14 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assay	Homo sapiens	2		cell-based format	Patent Bioactivity Data
11.	ALA4419242	F	Agonist activity at human TAS2R14 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level at 20 mM by Calcium-3 dye based fluorescence assay relative to control	Homo sapiens	3		cell-based format	Patent Bioactivity Data
12.	ALA4421743	F	Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R14 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as effect on intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	2		cell-based format	Patent Bioactivity Data
13.	ALA4421774	F	Activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R14 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as effect on aristolochic acids-induced intracellular calcium level at 100 uM by FLIPR assay	Homo sapiens	2		cell-based format	Patent Bioactivity Data
14.	ALA5251263	B	Agonist activity at human TAS2R14 transfected in HEK293T cells assessed as IP1 accumulation measured after 150 mins by IP1 accumulation assay	Homo sapiens	32		cell-based format	Scientific Literature
15.	ALA5251264	B	Agonist activity at human TAS2R14 transfected in HEK293T cells assessed as IP1 accumulation measured after 150 mins by IP1 accumulation assay relative to flufenamic acid	Homo sapiens	32		cell-based format	Scientific Literature
16.	ALA5251265	B	Agonist activity at human TAS2R14 transfected in HEK293T cells assessed as IP1 accumulation at 30 uM measured after 150 mins by IP1 accumulation assay relative to flufenamic acid	Homo sapiens	3		cell-based format	Scientific Literature
17.	ALA5251266	B	Agonist activity at human TAS2R14 transfected in HEK293T cells assessed as IP1 accumulation at 10 uM measured after 150 mins by IP1 accumulation assay relative to flufenamic acid	Homo sapiens	1		cell-based format	Scientific Literature
18.	ALA5251273	B	Partial agonist activity at human TAS2R14 transfected in HEK293T cells assessed as IP1 accumulation measured after 150 mins by IP1 accumulation assay	Homo sapiens	1		cell-based format	Scientific Literature
19.	ALA5251274	B	Partial agonist activity at human TAS2R14 transfected in HEK293T cells assessed as IP1 accumulation measured after 150 mins by IP1 accumulation assay relative to control	Homo sapiens	1		cell-based format	Scientific Literature
20.	ALA5251275	B	Potency index, ratio of flufenamic acid EC50 to test compound EC50 for human TAS2R14 transfected in HEK293T cells assessed as IP1 accumulation measured	Homo sapiens	1		cell-based format	Scientific Literature